TimeTeller: a New Tool for Precision Circadian Medicine and Cancer Prognosis
D. Vlachou, G. A. Bjarnason, S. Giacchetti, F. Levi, D. A. Rand
TimeTeller assesses circadian clock dysfunction using transcriptomics data and identifies it as a prognostic biomarker in breast cancer.
bioRxiv · Mar 11, 2020 · PreprintCancer Biology